MedTrace Logo

Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula

NCT01987154 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2016-05-17

No results posted yet for this study

Summary

To evaluate the use of a hypoallergenic infant formula containing an extensively hydrolyzed protein source for routine nutrition.

Conditions

  • Feeding Intolerance

Interventions

OTHER

Marketed cow milk-based premature infant formula

OTHER

Marketed extensively hydrolyzed casein infant formula

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Mariella Baldassarre, M.D. · Universita degli Studi di Bari

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01987154 on ClinicalTrials.gov